Jain, L., Sissung, T. M., Danesi, R., Kohn, E. C., Dahut, W. L., Kummar, S., . . . Figg, W. D. (2010). Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. BioMed Central.
Chicago Style CitationJain, Lokesh, et al. Hypertension and Hand-foot Skin Reactions Related to VEGFR2 Genotype and Improved Clinical Outcome Following Bevacizumab and Sorafenib. BioMed Central, 2010.
Cita MLAJain, Lokesh, et al. Hypertension and Hand-foot Skin Reactions Related to VEGFR2 Genotype and Improved Clinical Outcome Following Bevacizumab and Sorafenib. BioMed Central, 2010.
Atenció: Aquestes cites poden no estar 100% correctes.